Study Links Evodiamine to Cisplatin-Resistant Lung Cancer Targets
An integrative study identifies Evodiamine as a potential multi-target therapeutic agent against cisplatin-resistant non-small cell lung cancer by targeting key ...
An integrative study identifies Evodiamine as a potential multi-target therapeutic agent against cisplatin-resistant non-small cell lung cancer by targeting key ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.